Cited by 155Protein Structure and DynamicsEnzyme Structure and FunctionMachine Learning in Bioinformatics

The DOI matches its Crossref record; 109 of the 112 references it cites were found in a registry or an index, and 1 are not checked yet; 14 of the 132 sources its claims cite were checked for support.

The power and pitfalls of AlphaFold2 for structure prediction beyond rigid globular proteins

Open access
Agarwal, Vinayak, McShan, Andrew C.·2024·Nature Chemical Biology

Abstract

Artificial intelligence-driven advances in protein structure prediction in recent years have raised the question: has the protein structure-prediction problem been solved? Here, with a focus on nonglobular proteins, we highlight the many strengths and potential weaknesses of DeepMind's AlphaFold2 in the context of its biological and therapeutic applications. We summarize the subtleties associated with evaluation of AlphaFold2 model quality and reliability using the predicted local distance difference test (pLDDT) and predicted aligned error (PAE) values. We highlight various classes of proteins that AlphaFold2 can be applied to and the caveats involved. Concrete examples of how AlphaFold2 models can be integrated with experimental data in the form of small-angle X-ray scattering (SAXS), solution NMR, cryo-electron microscopy (cryo-EM) and X-ray diffraction are discussed. Finally, we highlight the need to move beyond structure prediction of rigid, static structural snapshots toward conformational ensembles and alternate biologically relevant states. The overarching theme is that careful consideration is due when using AlphaFold2-generated models to generate testable hypotheses and structural models, rather than treating predicted models as de facto ground truth structures.

Verified 2026-10-07 · 1 reference not checked yet

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review examines AlphaFold2’s strengths and failure modes for proteins beyond rigid globular folds, stressing that confidence scores do not guarantee agreement with experimental structures. It argues AF2 is best used as a hypothesis-generating complement to experimental data rather than as definitive structural truth.

Key findings

  • AF2 has broad coverage—modeling 98.5% of the human proteome, with over 200 million precomputed predictions in the AlphaFold Protein Structure Database—but accuracy varies by target class.
  • pLDDT and PAE are useful but imperfect: low pLDDT (<70) or high PAE (>5 Å) signal caution, yet high-confidence models can still deviate from experiments. On average, AF2 predicts about 50% of residues with high confidence, and one cited estimate suggests ~10% of high-confidence residues differ from native backbone by more than 2 Å.
  • Non-globular and dynamic systems are especially challenging: peptides were excluded from training, IDPs/IDRs are often conformational ensembles, membrane proteins are underrepresented in the PDB (<3%), and AF2 struggles with alternative conformations, ligand/cofactor effects, and domain placement. Heterodimeric complex success rates were reported at 51% and 63% in two benchmarks, with antibody complexes particularly difficult.
  • Integrating AF2 with SAXS, NMR, X-ray, and cryo-EM can improve models; AF-guided molecular replacement solved 187 of 215 structures in one benchmark, though cryo-EM maps worse than 6 Å are not recommended for fitting.

Methods

  • Narrative review/perspective, not a primary research study; no new experimental data or systematic meta-analysis are presented.
  • Synthesizes published benchmarks, case examples, and prior literature on AF2 workflow, pLDDT/PAE interpretation, protein classes, experimental integration, and conformational ensembles.
  • Uses selected examples—such as OSBP1, insulin, ChRmine, SecA, and beta-endorphin amyloid—to illustrate strengths and failure modes.

Limitations

  • Stated AF2 limitations include no training or validation for mutation effects, training bias toward soluble/PDB folds, peptide exclusion, membrane-protein underrepresentation, poor handling of IDPs/IDRs and alternative conformations, and cases where high pLDDT/PAE still mislead; inter-domain PAE accuracy is less benchmarked.
  • Evident from the text, not stated by the authors: as a narrative review, the selection of examples and benchmarks is not systematic, and the conclusions depend on the cited literature rather than new quantitative assessment.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41589-024-01638-w

Cites

109 of 110 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

71 Not checked yet · 15 Own interpretation · 8 No basis given · 4 Supported · 4 Partly supported · 4 Own result · accuracy not yet measured

Verify all 118 references — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 28
  • The quote only partly states this claim. 1
40 of 40

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 112 references

Research works printed but not linked: 6

  1. Bertoline, L. M. F., Lima, A. N., Krieger, J. E. & Teixeira, S. K. Before and after AlphaFold2: an overview of protein structure prediction. Front. Bioinform. 3, 1120370 (2023).
  2. Zhao, B., Ghadermarzi, S. & Kurgan, L. Comparative evaluation of AlphaFold2 and disorder predictors for prediction of intrinsic disorder, disorder content and fully disordered proteins. Comput. Struct. Biotechnol. J. 21, 3248–3258 (2023).
  3. McShan, A. C. Utility of methyl side chain probes for solution NMR studies of large proteins. J. Magn. Reson. Open 14–15, 100087 (2023).
  4. Ruschak, A. M. & Kay, L. E. Methyl groups as probes of supra-molecular structure, dynamics and function. J. Biomol. NMR 46, 75–87 (2009).
  5. Dai, X., Wu, L., Yoo, S. & Liu, Q. Integrating AlphaFold and deep learning for atomistic interpretation of cryo-EM maps. Brief. Bioinform. 24, bbad405 (2023).
  6. Johansson-Åkhe, I. & Wallner, B. Improving peptide–protein docking with AlphaFold-Multimer using forced sampling. Front. Bioinform. 2, 959160 (2022).

Cited by

Sorted by citations

See all 155

Metadata

Authors
Agarwal, V., & McShan, A. C.
Affiliations
Georgia Institute of Technology (US)
Corresponding author
  • Agarwal, Vinayak
  • McShan, Andrew C.
Venue
Nature Chemical Biology
Published
2024-06-21
Volume
20
Issue
8
Pages
950-959
ISSN
  • 1552-4450 (ISSN-L)
  • 1552-4469
OpenAlex
W4399893066
Cited by
155
References
112
Citations by year
2026: 79 · 2025: 63 · 2024: 13
FWCI
6.31
Type
journal article
Language
en
Open access
Locations
  • Nature Chemical Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion, other-oa)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM142882)
  • National Science Foundation (CHE-2238650)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
Keywords
AlphaFold2, protein structure prediction, intrinsically disordered proteins, conformational ensembles, model reliability, pLDDT, small-angle X-ray scattering, solution NMR, cryo-electron microscopy, X-ray diffraction
MeSH terms
Artificial Intelligence, Humans, Models, Molecular, Protein Conformation, Proteins, X-Ray Diffraction, Protein Folding, Cryoelectron Microscopy, Scattering, Small Angle

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review